Discover 2,122 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,122
Advanced Neuroimaging in Idiopathic Intracranial Hypertension
for
Idiopathic Intracranial Hypertension (IIH), Glymphatic System
Location: Philadelphia PA
Sponsor: Thomas Jefferson University
Sex: All
Age: 18 - 55
Code: NCT06950099
Recruiting
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
for
Depressive Disorder, Major
Location: Philadelphia PA, New York NY, Brooklyn NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 70+
Code: NCT06559306
Phase 3, Recruiting
TumorGlow Intraoperative Molecular Imaging (IMI)
for
Tumor, Solid
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 18+
Code: NCT04723810
Phase 1, Phase 2, Recruiting
Blood Glucose Stability and Variability on Two Diets
for
Type 2 Diabetes, Obesity
Location: Philadelphia PA
Sponsor: Nutrisystem, Inc.
Sex: All
Age: 18 - 65
Code: NCT01443143
Recruiting
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
for
Ewing Sarcoma, Osteosarcoma, Sarcomas
Location: Philadelphia PA, Aurora CO, San Francisco CA
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 5 - 40
Code: NCT06156410
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
for
Paroxysmal Atrial Fibrillation
Location: Philadelphia PA, Winchester VA, Richmond VA,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Sex: All
Age: 18+
Code: NCT06324201
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Location: Philadelphia PA, Newark DE, York PA, New York NY,
Sponsor: PMV Pharmaceuticals, Inc
Sex: All
Age: 12+
Code: NCT04585750
Phase 1, Phase 2, Recruiting
Pan Tumor Rollover Study
for
Cancer
Location: Lancaster PA, Mineola NY, Boston MA, Toronto,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT03899155
Phase 2, Recruiting
Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial
for
Post-ligation Cardiac Syndrome
Location: Philadelphia PA, Boston MA, Cleveland OH, Durham NC,
Sponsor: NICHD Neonatal Research Network
Sex: All
Age: 0
Code: NCT06679855
Phase 3, Recruiting
CW2IP2: Imaging and Diagnostic Assessments
for
Tauopathies
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 40 - 70+
Code: NCT06083467
Recruiting
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
for
Gestational Diabetes Mellitus, Pregnancy, High Risk
Location: Philadelphia PA, New York NY, New Haven CT,
Sponsor: Ohio State University
Sex: Female
Age: 18+
Code: NCT06445946
Recruiting
VCRC Tissue Repository
for
Aortitis, Cutaneous Vasculitis,
Location: Philadelphia PA, Hamilton, Toronto
Sponsor: University of Pennsylvania
Sex: All
Age: 0+
Code: NCT02967068
Recruiting
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
for
Multiple Myeloma
Location: Philadelphia PA, New Brunswick NJ, Hackensack NJ,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05201781
Recruiting
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
for
Pemphigus Vulgaris
Location: Philadelphia PA, New York NY, New Haven CT, Boston MA,
Sponsor: Cabaletta Bio
Sex: All
Age: 18+
Code: NCT04422912
Phase 1, Phase 2, Recruiting
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for
Graft-versus-host Disease (GVHD)
Location: Philadelphia PA, New York NY, Richmond VA, Boston MA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06615050
Phase 3, Recruiting
Descemet Endothelial Thickness Comparison Trial II